Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration

Intern Med J. 2014 May;44(5):519-21. doi: 10.1111/imj.12406.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Benzoates / therapeutic use*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications
  • Hepatitis C / complications
  • Humans
  • Hydrazines / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Platelet Count
  • Prednisolone / therapeutic use
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / etiology
  • Pyrazoles / therapeutic use*
  • Receptors, Fc / therapeutic use*
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombopoietin / therapeutic use*
  • Time Factors

Substances

  • Benzoates
  • Hydrazines
  • Immunosuppressive Agents
  • Pyrazoles
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • Prednisolone
  • romiplostim
  • eltrombopag